AVAX Counter-SAR sz10 6x (csar-transplant) is a community strategy by April Zoe. It trades AVAX on the 1D · 4H timeframe, long only. Version 1 was published on 2026-10-01.
Backtest of the published version on the Trigr engine over point-in-time market data, from 2020-09-23 to 2026-10-01: net return +1372.6%, Sharpe 1.66, max drawdown −20.9%, win rate 58%, 72 trades.
Costs. Trading fees and a builder fee of 4 bps per side are included. Slippage: not applied. Funding: not applied.
Forward paper track from 2026-10-01 to 2026-10-01 (0 days): return +0.0%, fees included. Paper fills are simulated on live market prices; this is not a funded account.
Past performance, backtested or paper, does not guarantee future results. Nothing here is investment advice.
